Related Experiment Video
Updated: Jan 25, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Post-Extubation Inhaled Nitric Oxide Therapy via High-Flow Nasal Cannula After Fontan Procedure
Yuji Tominaga1, Shigemitsu Iwai2, Sanae Yamauchi2
1Department of Cardiovascular Surgery, Osaka Women's and Children's Hospital, 840 Murodocho, Izumi, 594-1101, Osaka, Japan. ytomtomy@gmail.com.
High-flow nasal cannula inhaled nitric oxide (HFNC-iNO) therapy improved outcomes for patients after Fontan procedure. This approach reduced intubation time, pleural drainage, and hospitalization duration compared to iNO alone.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Critical Care Medicine
Background:
- The Fontan procedure is a complex surgery for single-ventricle congenital heart defects.
- Postoperative management of hemodynamically unstable patients after Fontan procedure requires optimized respiratory support.
- Inhaled nitric oxide (iNO) is used to improve pulmonary hemodynamics, but its efficacy can be enhanced with delivery methods like high-flow nasal cannula (HFNC).
Purpose of the Study:
- To evaluate the impact of adding HFNC to iNO therapy (HFNC-iNO) in patients extubated after Fontan procedure.
- To compare outcomes between patients receiving iNO alone versus those receiving HFNC-iNO therapy post-extubation.
Main Methods:
- Retrospective review of 38 patients undergoing Fontan procedure between January 2010 and June 2016.
- Patients were divided into two groups: Epoch 1 (n=24) received iNO therapy, and Epoch 2 (n=14) received iNO therapy plus HFNC-iNO post-extubation.
- Comparison of postoperative outcomes including intubation duration, pleural drainage, hospitalization length, and re-intubation rates.
Main Results:
- The HFNC-iNO group (Epoch 2) showed significantly shorter durations of postoperative intubation (3.5 vs. 7.2 hours), pleural drainage (9.5 vs. 23 days), and hospitalization (27 vs. 36 days).
- No patients in the HFNC-iNO group required re-intubation, compared to 8.3% in the iNO-only group.
- No significant differences were observed in preoperative characteristics or intensive care unit admission parameters between the groups.
Conclusions:
- The addition of HFNC to iNO therapy (HFNC-iNO) significantly improves postoperative recovery in patients after Fontan procedure.
- HFNC-iNO therapy is associated with reduced mechanical ventilation duration, pleural effusion, and overall hospital stay.
- This combined therapy represents a beneficial advancement in the management of unstable hemodynamics post-Fontan procedure.
Related Concept Videos
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Nitric Oxide Signaling Pathway
Handwashing III: During the Procedure and Post-Procedure Steps
Endotracheal Tube Extubation
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
Inhaled Medications

